메뉴 건너뛰기




Volumn 102, Issue 4, 2005, Pages 341-348

Strategies for the immunosuppressive therapy of intraocular inflammation;Strategien zur immunsuppressiven therapie intraokularer entzündungen

Author keywords

Corticosteroids; Immunosuppression; Methotrexate; Uveitis

Indexed keywords

ANTIMETABOLITE; AZAFALK; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LANTAREL; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; SANDIMMUN OPTORAL;

EID: 17744393222     PISSN: 0941293X     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-004-1167-1     Document Type: Review
Times cited : (3)

References (8)
  • 1
    • 0029926353 scopus 로고    scopus 로고
    • Adverse effects of bisphosphonates. A comparative review
    • Adami S, Zamberlan N (1996) Adverse effects of bisphosphonates. A comparative review. Drug Saf 3:158-170
    • (1996) Drug Saf , vol.3 , pp. 158-170
    • Adami, S.1    Zamberlan, N.2
  • 2
    • 0034944221 scopus 로고    scopus 로고
    • Recommendations for the prevention and treatment of glucocorticoid- induced osteoporosis: 2001 Update
    • American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 7:1496-1503
    • (2001) Arthritis Rheum , vol.7 , pp. 1496-1503
  • 3
    • 0033668811 scopus 로고    scopus 로고
    • Current and future trends in the use of immunosuppressive agents in patients with uveitis
    • Becker MD, Rosenbaum JT (2000) Current and future trends in the use of immunosuppressive agents in patients with uveitis. Curr Opin Ophthalmol 6:472-477
    • (2000) Curr Opin Ophthalmol , vol.6 , pp. 472-477
    • Becker, M.D.1    Rosenbaum, J.T.2
  • 4
    • 16344364887 scopus 로고    scopus 로고
    • Management of sight-threatening uveitis: New therapeutic options
    • im Druck
    • Becker MD, Smith JR, Max R et al. (2005) Management of sight-threatening uveitis: new therapeutic options. Drugs (im Druck)
    • (2005) Drugs
    • Becker, M.D.1    Smith, J.R.2    Max, R.3
  • 5
    • 1642331531 scopus 로고    scopus 로고
    • Experience with cyclosporine in endogenous uveitis posterior
    • Hesselink DA, Baarsma GS, Kuijpers RW et al. (2004) Experience with cyclosporine in endogenous uveitis posterior.Transplant Proc 2 [Suppl]:372S-377S
    • (2004) Transplant Proc , vol.2 , Issue.SUPPL.
    • Hesselink, D.A.1    Baarsma, G.S.2    Kuijpers, R.W.3
  • 6
    • 0033807387 scopus 로고    scopus 로고
    • Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel
    • Jabs DA, Rosenbaum JT, Foster CS et al. (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 4:492-513
    • (2000) Am J Ophthalmol , vol.4 , pp. 492-513
    • Jabs, D.A.1    Rosenbaum, J.T.2    Foster, C.S.3
  • 7
    • 0036740845 scopus 로고    scopus 로고
    • Corticosteroid-induced osteoporosis in patients with uveitis
    • Jones NP, Anderton LC, Cheong FM et al. (2002) Corticosteroid-induced osteoporosis in patients with uveitis. Eye 5:587-593
    • (2002) Eye , vol.5 , pp. 587-593
    • Jones, N.P.1    Anderton, L.C.2    Cheong, F.M.3
  • 8
    • 0036709834 scopus 로고    scopus 로고
    • Corticosteroids in uveitis
    • Rothova A (2002) Corticosteroids in uveitis. Ophthalmol Clin North Am 3:389-394
    • (2002) Ophthalmol Clin North Am , vol.3 , pp. 389-394
    • Rothova, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.